We are live on ! Find out more
FCM

FourWorld Capital Management Portfolio holdings

AUM $196M
1-Year Est. Return 42.39%
This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
+42.39%
3 Year Est. Return
+114.45%
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
+$18.8M
Cap. Flow
+$12.4M
Cap. Flow %
6.43%
Top 10 Hldgs %
97.19%
Holding
32
New
5
Increased
6
Reduced
3
Closed
11

Sector Composition

Rank Sector Weight
1 Communication Services 48.32%
2 Financials 34.9%
3 Healthcare 4.52%
4 Industrials 4.23%
5 Real Estate 2.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILF icon
26
iShares Latin America 40 ETF
ILF
$3.76B
-10,743
Closed -$278K
IRTC icon
27
iRhythm Holdings
IRTC
$4.2B
-5,750
Closed -$427K
IWM icon
28
iShares Russell 2000 ETF
IWM
$83B
-3,000
Closed -$663K
OMEX icon
29
Odyssey Marine Exploration
OMEX
$51.8M
-3,029,741
Closed -$2.51M
SPY icon
30
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
-105,000
Closed -$60.2M
TPIC
31
DELISTED
TPI Composites
TPIC
-20,400
Closed -$92.8K
VGK icon
32
Vanguard FTSE Europe ETF
VGK
$31.4B
-8,304
Closed -$590K

Similar funds

FourWorld Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, FourWorld Capital Management held 32 positions worth $192M, up 11% from $174M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

FourWorld Capital Management deployed $12.4M of net new capital in Q4 2024, opening 5 new positions and adding to 6 existing holdings. Its largest new stake was Enstar Group: 208,600 shares worth $67.2M.

By sector, the portfolio is most concentrated in Communication Services at 48% of assets, up from 38% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $6.42M trimmed.

  • FourWorld Capital Management's largest Q4 2024 buy was Enstar Group: 208,600 shares worth $67.2M.
  • FourWorld Capital Management added most to Endeavor Group Holdings, Inc. in Q4 2024, an estimated $19.6M increase.
  • FourWorld Capital Management's biggest Q4 2024 reduction was Arbutus Biopharma, cutting an estimated $6.42M.
  • FourWorld Capital Management fully exited Albertsons Companies in Q4 2024, selling an estimated $3.7M.
  • FourWorld Capital Management's ten largest holdings make up 97% of its $192M portfolio in Q4 2024.
  • FourWorld Capital Management opened 5 new positions and closed 11 in Q4 2024.
  • FourWorld Capital Management's portfolio value rose 11% quarter-over-quarter to $192M.

Based on FourWorld Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.